12 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
this therapy to patients world-wide,” said Giuseppe Accogli, Group CEO of Chiesi. “Gossamer shares Chiesi’s commitment to using innovation to promote the health
10-K
5ujg6p2ol8j4l0
22 Mar 19
Annual report
4:45pm
424B4
z7wmx8mho3mwrh7ufh
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
q1pcvrpmikf
23 Jan 19
IPO registration (amended)
4:39pm
S-1
xqek7848htz9o4
21 Dec 18
IPO registration
4:39pm
DRS/A
6anm9k0 pao4z3n4kw
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
sn8e2usj
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next